Report Detail

Pharma & Healthcare Global Imatinib Drug Market Professional Survey Report 2019

  • RnM3812411
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 101 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Imatinib Drug

      • 1.1 Definition of Imatinib Drug
      • 1.2 Imatinib Drug Segment by Type
        • 1.2.1 Global Imatinib Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Tablets
        • 1.2.3 Capsules
      • 1.3 Imatinib Drug Segment by Applications
        • 1.3.1 Global Imatinib Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Chronic myelogenous leukemia
        • 1.3.3 Gastrointestinal stromal tumors
        • 1.3.4 Others
      • 1.4 Global Imatinib Drug Overall Market
        • 1.4.1 Global Imatinib Drug Revenue (2014-2025)
        • 1.4.2 Global Imatinib Drug Production (2014-2025)
        • 1.4.3 North America Imatinib Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Imatinib Drug Status and Prospect (2014-2025)
        • 1.4.5 China Imatinib Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Imatinib Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Imatinib Drug Status and Prospect (2014-2025)
        • 1.4.8 India Imatinib Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Imatinib Drug
      • 2.3 Manufacturing Process Analysis of Imatinib Drug
      • 2.4 Industry Chain Structure of Imatinib Drug

      3 Development and Manufacturing Plants Analysis of Imatinib Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Imatinib Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Imatinib Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Imatinib Drug Production and Capacity Analysis
      • 4.2 Imatinib Drug Revenue Analysis
      • 4.3 Imatinib Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Imatinib Drug Regional Market Analysis

      • 5.1 Imatinib Drug Production by Regions
        • 5.1.1 Global Imatinib Drug Production by Regions
        • 5.1.2 Global Imatinib Drug Revenue by Regions
      • 5.2 Imatinib Drug Consumption by Regions
      • 5.3 North America Imatinib Drug Market Analysis
        • 5.3.1 North America Imatinib Drug Production
        • 5.3.2 North America Imatinib Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Imatinib Drug Import and Export
      • 5.4 Europe Imatinib Drug Market Analysis
        • 5.4.1 Europe Imatinib Drug Production
        • 5.4.2 Europe Imatinib Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Imatinib Drug Import and Export
      • 5.5 China Imatinib Drug Market Analysis
        • 5.5.1 China Imatinib Drug Production
        • 5.5.2 China Imatinib Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Imatinib Drug Import and Export
      • 5.6 Japan Imatinib Drug Market Analysis
        • 5.6.1 Japan Imatinib Drug Production
        • 5.6.2 Japan Imatinib Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Imatinib Drug Import and Export
      • 5.7 Southeast Asia Imatinib Drug Market Analysis
        • 5.7.1 Southeast Asia Imatinib Drug Production
        • 5.7.2 Southeast Asia Imatinib Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Imatinib Drug Import and Export
      • 5.8 India Imatinib Drug Market Analysis
        • 5.8.1 India Imatinib Drug Production
        • 5.8.2 India Imatinib Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Imatinib Drug Import and Export

      6 Imatinib Drug Segment Market Analysis (by Type)

      • 6.1 Global Imatinib Drug Production by Type
      • 6.2 Global Imatinib Drug Revenue by Type
      • 6.3 Imatinib Drug Price by Type

      7 Imatinib Drug Segment Market Analysis (by Application)

      • 7.1 Global Imatinib Drug Consumption by Application
      • 7.2 Global Imatinib Drug Consumption Market Share by Application (2014-2019)

      8 Imatinib Drug Major Manufacturers Analysis

      • 8.1 Novartis
        • 8.1.1 Novartis Imatinib Drug Production Sites and Area Served
        • 8.1.2 Novartis Product Introduction, Application and Specification
        • 8.1.3 Novartis Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Glenmark Pharmaceuticals Ltd.
        • 8.2.1 Glenmark Pharmaceuticals Ltd. Imatinib Drug Production Sites and Area Served
        • 8.2.2 Glenmark Pharmaceuticals Ltd. Product Introduction, Application and Specification
        • 8.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sun Pharmaceuticals
        • 8.3.1 Sun Pharmaceuticals Imatinib Drug Production Sites and Area Served
        • 8.3.2 Sun Pharmaceuticals Product Introduction, Application and Specification
        • 8.3.3 Sun Pharmaceuticals Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Actavis Generics
        • 8.4.1 Actavis Generics Imatinib Drug Production Sites and Area Served
        • 8.4.2 Actavis Generics Product Introduction, Application and Specification
        • 8.4.3 Actavis Generics Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Dr. Reddy's Laboratories
        • 8.5.1 Dr. Reddy's Laboratories Imatinib Drug Production Sites and Area Served
        • 8.5.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
        • 8.5.3 Dr. Reddy's Laboratories Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Teva Pharmaceutical Industries Ltd.
        • 8.6.1 Teva Pharmaceutical Industries Ltd. Imatinib Drug Production Sites and Area Served
        • 8.6.2 Teva Pharmaceutical Industries Ltd. Product Introduction, Application and Specification
        • 8.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi S.A.
        • 8.7.1 Sanofi S.A. Imatinib Drug Production Sites and Area Served
        • 8.7.2 Sanofi S.A. Product Introduction, Application and Specification
        • 8.7.3 Sanofi S.A. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Cipla Inc.
        • 8.8.1 Cipla Inc. Imatinib Drug Production Sites and Area Served
        • 8.8.2 Cipla Inc. Product Introduction, Application and Specification
        • 8.8.3 Cipla Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Apotex Inc.
        • 8.9.1 Apotex Inc. Imatinib Drug Production Sites and Area Served
        • 8.9.2 Apotex Inc. Product Introduction, Application and Specification
        • 8.9.3 Apotex Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Mylan Pharms Inc.
        • 8.10.1 Mylan Pharms Inc. Imatinib Drug Production Sites and Area Served
        • 8.10.2 Mylan Pharms Inc. Product Introduction, Application and Specification
        • 8.10.3 Mylan Pharms Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Imatinib Drug Market

      • 9.1 Global Imatinib Drug Market Trend Analysis
        • 9.1.1 Global Imatinib Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Imatinib Drug Regional Market Trend
        • 9.2.1 North America Imatinib Drug Forecast 2019-2025
        • 9.2.2 Europe Imatinib Drug Forecast 2019-2025
        • 9.2.3 China Imatinib Drug Forecast 2019-2025
        • 9.2.4 Japan Imatinib Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Imatinib Drug Forecast 2019-2025
        • 9.2.6 India Imatinib Drug Forecast 2019-2025
      • 9.3 Imatinib Drug Market Trend (Product Type)
      • 9.4 Imatinib Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Imatinib Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

        Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.

        The global Imatinib Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Imatinib Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Imatinib Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Novartis
        Glenmark Pharmaceuticals Ltd.
        Sun Pharmaceuticals
        Actavis Generics
        Dr. Reddy's Laboratories
        Teva Pharmaceutical Industries Ltd.
        Sanofi S.A.
        Cipla Inc.
        Apotex Inc.
        Mylan Pharms Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Tablets
        Capsules

        Segment by Application
        Chronic myelogenous leukemia
        Gastrointestinal stromal tumors
        Others


        Summary:
        Get latest Market Research Reports on Imatinib Drug. Industry analysis & Market Report on Imatinib Drug is a syndicated market report, published as Global Imatinib Drug Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Imatinib Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,775.50
        4,163.25
        5,551.00
        3,171.80
        4,757.70
        6,343.60
        379,351.00
        569,026.50
        758,702.00
        248,712.10
        373,068.15
        497,424.20
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report